MedAdvisor Limited announced the appointment of Kevin Hutchinson as a non-executive director effective 23 November 2022. With over 35 years' experience in technology, Mr. Hutchinson has extensive leadership experience and a successful track record in the development and deployment of innovative technology companies in the healthcare sector in the US. He is currently working with Abundant Venture Partners to incubate a company, AXL Health, focused on providing precision patient intelligence to increase health coverage, reduce health disparities, and improve the management of chronic disease.

Previously, Mr. Hutchison served in multiple senior roles within healthcare technology start-ups and growth stage ventures, including being the founding CEO of Surescripts, the first nation-wide SaaS-based health information network company in the US. Highly regarded for his digital innovation expertise in the healthcare sector in the US, Mr. Hutchison's extensive experience and achievements include leading teams that: developed one of the first electronic medical record solutions; delivered a mobile app for providers to close gaps in care; and built and grew the largest health intelligence sharing network that serves the US market nationally to prescribe medications electronically, being appointed by two US Presidential administrations to advise on national health IT strategies, serving on seven boards including health technology businesses Eon Health, Kit Check, SourceMed, dbMotion, Prematics, Surescripts and Apervita. Mr. Hutchison holds a Bachelor's degree in Business Administration from the University of Oklahoma and was a recipient of the 2015 Distinguished Alumni Award.

Having provided continuity and support to the Company through a transition period following the appointment of Rick Ratliff as CEO and Managing Director, current Executive Director RobertRead will be stepping down from the Board and his role at MedAdvisor on 30 November 2022 and will not be seeking re-election at the upcoming AGM.